Blood immune cells predicted worse MS after a first attack
Key Takeaway
At a first MS-like attack, higher levels of certain blood immune cells predicted a more severe MS course two years later.
What They Found
Researchers found a group of blood immune cells linked to relapsing MS. These cells increased around the time of relapses. At a first MS-like attack, higher levels predicted a more severe MS course two years later. Lab tests showed these cells could kill other cells without their usual trigger. The cells were also found in areas of MS damage in the brain.
Who Should Care and Why
The study examined people with relapsing MS, people at their first MS-like attack, healthy volunteers, and people with other inflammatory conditions affecting the nervous system. It focused on immune cells in the blood. Researchers also examined areas of MS damage in the brain. The findings link blood immune cells to both relapses and later MS severity. They may help researchers study an early way to predict how MS will progress.
Important Considerations
You cannot use this finding to predict your own MS course. The abstract does not report how many people took part or how accurately the blood finding predicted later severity. Researchers observed these links and ran lab tests; they did not test a treatment.
AI-generated summary — for informational purposes only, not medical advice
Categories:
Article Topics:
You May Also Like
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More
9/28/2026
A review of 17 people with worsening weakness found rare brain lesions along movement pathways. Some
Read More
9/28/2026
In 179 people with MS, narrower eye blood vessels were linked to greater disability. Combining vesse
Read More
9/27/2026
Researchers compared people with MS and people without MS. A nerve protein suggested older age in MS
Read More
9/26/2026
In a Swedish study of 3,094 people with MS, family history was not linked to worse long-term disabil
Read More
9/26/2026
A Swedish study linked more leisure-time activity to lower MS risk among people with less sun exposu
Read MoreUnderstanding MS Research
Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Brain : a journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.